Log In
Print this Print this

Clopidogrel Genetic Absorption Activation Panel (C-GAAP) (formerly PGxPredict:Clopidogrel Panel)

  Manage Alerts
Collapse Summary General Information
Company Transgenomic Inc.
DescriptionDetects deficiencies associated with genes CYP2C19 and ABCB1
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsAid in predicting patient response to clopidogrel
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today